Review Article
An Updated List of Neuromedicinal Plants of Pakistan, Their Uses, and Phytochemistry
Table 1
Global epidemiology of neurological diseases and theircomparative prevalence in Pakistan and neighboring countries.
| ā | Migraine | Stroke | Epilepsy | Depression | Anxiety | Parkinson | Alzheimer |
| Worldwide | 14.9% [49] | 5% [50] | 0.5-1% [51] | 4.4% [52] | 3.6% [52] | 1% [53] | 11.2% [54] | Asia | 9.1% [55] | 0.94%[56] | 0.49% [57] | 4.4% [52] | 2.8% [58] | 0.63% [59] | 1.9% [54] | Africa | 5.61% [60] | 0.4% [61] | 1.13% [62] | 5.2% [52] | 4.4% [52] | 0.44% [63] | 1.6% [54] | North America | 14.4% [64] | 2.7% [65] | 0.8% [66] | 10.6% [67] | 7.7% [58] | 1.3% [59] | 6.4% [54] | South America | 11.6% [64] | 0.7% [68] | 0.98% [57] | 13.8% [67] | 10.4% [69] | 2.3% [59] | 4.6% [54] | Europe | 15% [70] | 6.25%[71] | 0.82% [62] | 4.2% [52] | 3.9% [52] | 1.6% [72] | 4.4% [54] | Australia | 6% [73] | 1.8% [74] | 0.44% [75] | 5.9% [52] | 7% [52] | 0.46% [76] | 6.4% [77] | Pakistan | 26.1% [78] | 0.25% [79] | 2% [4] | 4.2% [52] | 3.5% [52] | 0.23% [51] | 1% [4] | India | 25.2% [51] | 3.69%[71] | 0.39% [80] | 4.5% [52] | 3.0% [52] | 0.07% [81] | 1.91% [82] | Iran | 14% [51] | 0.36% [51] | 1.8% [80] | 4.9% [52] | 4.6% [52] | 0.29% [83] | 2.3% [84] | China | 9.3% [78] | 4.3% [71] | 0.3% [80] | 4.2% [52] | 3.1% [52] | 1.7 % [85] | 3.21% [85] | Afghanistan | 0.9% [86] | 5.2% [87] | 8.9% [88] | 51.8% [89] | 38.5% [89] | 35.4% [90] | 15.3% [91] |
|
|